| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CH5424802 | GDSC1000 | pan-cancer | AAC | 0.39 | 9e-32 |
| mRNA | MPS-1-IN-1 | GDSC1000 | pan-cancer | AAC | 0.25 | 3e-15 |
| mRNA | XMD14-99 | GDSC1000 | pan-cancer | AAC | 0.2 | 4e-09 |
| mRNA | Crizotinib | GDSC1000 | pan-cancer | AAC | 0.31 | 8e-09 |
| mRNA | BRD-K94991378 | CTRPv2 | pan-cancer | AAC | 0.22 | 9e-09 |
| mRNA | ABT-199 | CTRPv2 | pan-cancer | AAC | 0.24 | 2e-08 |
| mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | 0.19 | 7e-08 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | -0.18 | 9e-08 |
| mRNA | XMD15-27 | GDSC1000 | pan-cancer | AAC | 0.18 | 1e-07 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | -0.17 | 1e-07 |